TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
Study Type
OBSERVATIONAL
Enrollment
10,000
Establish a longitudinal observational cohort to understand the natural history and management of HCC, including the safety and outcomes of HCC treatment interventions utilized in usual clinical practice
Time frame: Up to 15 years
Evaluate the impact of HCC treatment interventions and concomitant medications on comorbid conditions and liver function
Time frame: Up to 15 years
Evaluate patient-reported outcomes measures during the natural course of HCC and management with HRQoL questionnaires
Time frame: Up to 15 years
Establish a Biorepository Specimen Bank (BSB)
Time frame: Up to 15 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Banner University Medical Center
Phoenix, Arizona, United States
University of Arkansas
Little Rock, Arkansas, United States
University of Southern California/Norris Comprehensive Cancer Center
Los Angeles, California, United States
Stanford University
Palo Alto, California, United States
California Liver Research Institute
Pasadena, California, United States
University of California-Davis
Sacramento, California, United States
University of California
San Francisco, California, United States
Georgetown University
Washington D.C., District of Columbia, United States
Gastro Florida
Clearwater, Florida, United States
University of Florida Hepatology Research at CTRB
Gainesville, Florida, United States
...and 61 more locations